E Point Perfect – Interesting and beneficial content
Law \ Legal

FDA Webinar on Genome-Edited Animals for Food Use


  • On June 27, 2022, FDA’s Center for Veterinary Medicine (CVM) announced that it had published a pre-recorded animal biotechnology case study webinar. The webinar addresses the agency’s risk-based review process for intentional genomic alterations (IGAs) in animals that may pose a low risk.
  • As previously reported, on March 7, 2022, FDA announced its first low-risk determination for the marketing of products from genome-edited beef cattle and their offspring, following a safety review. CVM’s webinar uses this evaluation as a case study to provide insight into how the agency reached its determination that the IGA did not raise any safety concerns.
  • By way of background, IGAs in animals are changes to an animal’s genomic DNA that are produced using modern molecular technologies, such as random or targeted DNA sequence changes. The intended uses for IGAs in animals include applications in human health (e.g., reducing allergenicity), improved animal health (e.g., disease resistance), and enhanced production of food quality (e.g., feed efficiency).  FDA’s draft guidance notes that FDA will exercise enforcement discretion where it determines that alterations present a low risk of harm.
  • CVM will accept feedback and questions regarding the webinar at FDA-CVM-Animal-Biotechnology-Feedback@fda.hhs.gov. Additional resources on IGAs can be found here.


Source link

Related posts

Illinois Employment Law – When A Background Check Is Wrong

HHS Issues HIPAA Guidance on Remote Communication Technologies for Audio-Only Telehealth

Book Review of The Appellate Prosecutor

FTC Issues New Business Guidance for Marketers and Sellers of Health Products

EEOC Walks Back its Advice on When Workplace COVID Testing is Appropriate

Scary Stories about our Wicked Problems (Legal Nerd Halloween)